what is tirzepatide glp 1 Compound Republican Administration Maintains Exclusivity Stance
Description
Ozempic (semaglutide) is FDA-approved for type 2 diabetes, not obesity or weight management
Retatrutide has higher nausea, vomiting, and diarrhea rates across all dose levels
Next, the boundary between PZ and Transition Zone (TZ) was determined by conventional criteria [95]
Approved in November 2023, Zepbound is a dual agonist targeting both GLP-1 and GIP receptors
